X0508 4 2025-05-01 false 0001710072 Edgewise Therapeutics, Inc. EWTX 0001644467 Carruthers R Michael C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET BOULDER CO 80301 false true false false Chief Financial Officer false Common Stock 2025-05-01 4 M false 5209.00 0.00 A 82328.00 D Common Stock 2025-05-02 4 S false 1314.00 16.4542 D 81014.00 D Restricted Stock Units 0.00 2025-05-01 4 M false 5209.00 0.00 D 2025-05-02 2032-05-01 Common Stock 5209.00 0.00 D Includes 215 shares purchased on November 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan. Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.84, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ John R. Moore Attorney-in-Fact for R. Michael Carruthers 2025-05-07